Patient-specific deep learning tracking for real-time 2D pancreas localisation in kV-guided radiotherapy

Background and purpose

In pancreatic stereotactic body radiotherapy (SBRT), accurate motion management is crucial for the safe delivery of high doses per fraction. Intra-fraction tracking with magnetic resonance imaging-guidance for gated SBRT has shown potential for improved local control. Visualisation of pancreas (and surrounding organs) remains challenging in intra-fraction kilo-voltage (kV) imaging, requiring implanted fiducials. In this study, we investigate patient-specific deep-learning approaches to track the gross-tumour-volume (GTV), pancreas-head and the whole-pancreas in intra-fraction kV images.

Materials and methods

Conditional-generative-adversarial-networks were trained and tested on data from 25 patients enrolled in an ethics-approved pancreatic SBRT trial for contour prediction on intra-fraction 2D kV images. Labelled digitally-reconstructed-radiographs (DRRs) were generated from contoured planning-computed-tomography (CTs) (CT-DRRs) and cone-beam-CTs (CBCT-DRRs). A population model was trained using CT-DRRs of 19 patients. Two patient-specific model types were created for six additional patients by fine-tuning the population model using CBCT-DRRs (CBCT-models) or CT-DRRs (CT-models) acquired in exhale-breath-hold. Model predictions on unseen triggered-kV images from the corresponding six patients were evaluated against projected-contours using Dice-Similarity-Coefficient (DSC), centroid-error (CE), average Hausdorff-distance (AHD), and Hausdorff-distance at 95th-percentile (HD95).

Results

The mean ± 1SD (standard-deviation) DSCs were 0.86 ± 0.09 (CBCT-models) and 0.78 ± 0.12 (CT-models). For AHD and CE, the CBCT-model predicted contours within 2.0 mm ≥90.3 % of the time, while HD95 was within 5.0 mm ≥90.0 % of the time, and had a prediction time of 29.2 ± 3.7 ms per contour.

Conclusion

The patient-specific CBCT-models outperformed the CT-models and predicted the three contours with 90th-percentile error ≤2.0 mm, indicating the potential for clinical real-time application.